Drug Approval | February 20, 2025
Orchid Pharma's Alathur API facility successfully completes USFDA inspection
The Alathur facility specializes in the production of Cephalosporin antibiotics
The Alathur facility specializes in the production of Cephalosporin antibiotics
_256_384.jpg)
Hikal Limited announces the completion of the US Food and Drug Administration (USFDA) inspection at its Jigani unit, Bengaluru
EBITDA grew by 11% on a YoY basis to Rs. 296 crore due to improved performance in CDMO Sterile Injectables, CRDMO and Generics
This certification will open new markets for the Kwality Pharma
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
The approved product has an estimated market size of US$ 106 million for the twelve months ending October 2024, according to IQVIA
The product will be marketed by Dr. Reddy's
Subscribe To Our Newsletter & Stay Updated
